# BTM-3566 in Advanced Solid Tumors

> **NCT07266285** · PHASE1 · RECRUITING · sponsor: **Bantam Pharmaceuticals** · enrollment: 30 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** BTM-3566

## Key facts

- **NCT ID:** NCT07266285
- **Lead sponsor:** Bantam Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-10
- **Primary completion:** 2027-02
- **Final completion:** 2027-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07266285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07266285, "BTM-3566 in Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07266285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*